These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11721634)

  • 1. Proteomics of breast cancer for marker discovery and signal pathway profiling.
    Hondermarck H; Vercoutter-Edouart AS; Révillion F; Lemoine J; el-Yazidi-Belkoura I; Nurcombe V; Peyrat JP
    Proteomics; 2001 Oct; 1(10):1216-32. PubMed ID: 11721634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth signaling in breast cancer cells: outcomes and promises of proteomics.
    Adriaenssens E; Lemoine J; El Yazidi-Belkoura I; Hondermarck H
    Biochem Pharmacol; 2002 Sep; 64(5-6):797-803. PubMed ID: 12213572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics of breast cancer: outcomes and prospects.
    El Yazidi-Belkoura I; Adriaenssens E; Vercoutter-Edouart AS; Lemoine J; Nurcombe V; Hondermarck H
    Technol Cancer Res Treat; 2002 Aug; 1(4):287-96. PubMed ID: 12625788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional proteomics of breast cancer for signal pathway profiling and target discovery.
    Hondermarck H; Dollé L; El Yazidi-Belkoura I; Vercoutter-Edouart AS; Adriaenssens E; Lemoine J
    J Mammary Gland Biol Neoplasia; 2002 Oct; 7(4):395-405. PubMed ID: 12882524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic study reveals that proteins involved in metabolic and detoxification pathways are highly expressed in HER-2/neu-positive breast cancer.
    Zhang D; Tai LK; Wong LL; Chiu LL; Sethi SK; Koay ES
    Mol Cell Proteomics; 2005 Nov; 4(11):1686-96. PubMed ID: 16048908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretomic and proteomic analysis of potential breast cancer markers by two-dimensional differential gel electrophoresis.
    Lai TC; Chou HC; Chen YW; Lee TR; Chan HT; Shen HH; Lee WT; Lin ST; Lu YC; Wu CL; Chan HL
    J Proteome Res; 2010 Mar; 9(3):1302-22. PubMed ID: 20052998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass spectrometric characterization of protein structure details refines the proteome signature for invasive ductal breast carcinoma.
    Röwer C; Koy C; Hecker M; Reimer T; Gerber B; Thiesen HJ; Glocker MO
    J Am Soc Mass Spectrom; 2011 Mar; 22(3):440-56. PubMed ID: 21472563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative proteomics of primary breast carcinomas and lymph node metastases outlining markers of tumor invasion.
    Milioli HH; Santos Sousa K; Kaviski R; Dos Santos Oliveira NC; De Andrade Urban C; De Lima RS; Cavalli IJ; De Souza Fonseca Ribeiro EM
    Cancer Genomics Proteomics; 2015; 12(2):89-101. PubMed ID: 25770193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.
    Celis JE; Gromov P; Cabezón T; Moreira JM; Ambartsumian N; Sandelin K; Rank F; Gromova I
    Mol Cell Proteomics; 2004 Apr; 3(4):327-44. PubMed ID: 14754989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative proteomic analysis of different stages of breast cancer tissues using ultra high performance liquid chromatography tandem mass spectrometer.
    Al-Wajeeh AS; Salhimi SM; Al-Mansoub MA; Khalid IA; Harvey TM; Latiff A; Ismail MN
    PLoS One; 2020; 15(1):e0227404. PubMed ID: 31945087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis reveals that 14-3-3sigma is down-regulated in human breast cancer cells.
    Vercoutter-Edouart AS; Lemoine J; Le Bourhis X; Louis H; Boilly B; Nurcombe V; Révillion F; Peyrat JP; Hondermarck H
    Cancer Res; 2001 Jan; 61(1):76-80. PubMed ID: 11196201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast.
    Somiari RI; Sullivan A; Russell S; Somiari S; Hu H; Jordan R; George A; Katenhusen R; Buchowiecka A; Arciero C; Brzeski H; Hooke J; Shriver C
    Proteomics; 2003 Oct; 3(10):1863-73. PubMed ID: 14625848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative proteomic analysis of beta-catenin-mediated malignant progression of esophageal squamous cell carcinoma.
    Ren HZ; Wang JS; Pan GQ; Lv H; Wen JF; Luo GQ; Wang KS; Zhang PF
    Dis Esophagus; 2010 Feb; 23(2):175-84. PubMed ID: 19664078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential predictive plasma biomarkers for cervical cancer by 2D-DIGE proteomics and Ingenuity Pathway Analysis.
    Guo X; Hao Y; Kamilijiang M; Hasimu A; Yuan J; Wu G; Reyimu H; Kadeer N; Abudula A
    Tumour Biol; 2015 Mar; 36(3):1711-20. PubMed ID: 25427637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer proteomics: a review for clinicians.
    Galvão ER; Martins LM; Ibiapina JO; Andrade HM; Monte SJ
    J Cancer Res Clin Oncol; 2011 Jun; 137(6):915-25. PubMed ID: 21465318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis to identify breast cancer biomarkers in nipple aspirate fluid.
    Alexander H; Stegner AL; Wagner-Mann C; Du Bois GC; Alexander S; Sauter ER
    Clin Cancer Res; 2004 Nov; 10(22):7500-10. PubMed ID: 15569980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma.
    Zhou X; Xue L; Hao L; Liu S; Zhou F; Xiong H; Qi X; Lin D; Shao S
    Biomed Pharmacother; 2013 Sep; 67(7):621-7. PubMed ID: 23916545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches to proteomic analysis of breast cancer.
    Wulfkuhle JD; McLean KC; Paweletz CP; Sgroi DC; Trock BJ; Steeg PS; Petricoin EF
    Proteomics; 2001 Oct; 1(10):1205-15. PubMed ID: 11721633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer proteomics using two-dimensional electrophoresis: studying the breast cancer proteome.
    Dwek MV; Rawlings SL
    Methods Mol Med; 2006; 120():231-43. PubMed ID: 16491605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics pipeline for biomarker discovery of laser capture microdissected breast cancer tissue.
    Liu NQ; Braakman RB; Stingl C; Luider TM; Martens JW; Foekens JA; Umar A
    J Mammary Gland Biol Neoplasia; 2012 Jun; 17(2):155-64. PubMed ID: 22644111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.